INTRODUCTION

Group B coxsackievirus
(CoxB) is a pathogen which causes a wide spectrum of diseases in man, ranging from mild respiratory illness to severe myocarditis (1) (2) (3) (4) . A half of the viral myocarditis cases were attributed to CoxB virus (5) and 34.2% of them to type 3, CoxB3 (6). Lindberg and his colleges (7 ,8) sequenced the entire genome of CoxB3; there was a considerable variability in the nucleotide sequence among the isolates (9, 10) . Such sequence analysis greatly contributes to Virus: Coxsackie B virus prototypes, CoxBl Conn-5, CoxB2 Ohio-1, CoxB3 Nancy, CoxB4 JVB, CoxB5 Faulkner and CoxB6 Schmidt, were provided by Chinese Academy of Medical Sciences, Institute of Medical Biology, Kunming, China. Three CoxB3 strains, F1, F2 and F3, were isolated from the stools of myocarditis patients in Fujiang province, China. CoxB3 (N), F1, F2 and F3 were plaquepurified twice on monolayers of the buffalo green monkey kidney (BGMK) cells to obtain two clones (C1 and C2) from each strain (Table II) . All the viruses were clarified by centrifugation at 3,000 rpm for 20 min and stored at -20 C.
Monoclonal antibodies (McAbs) to CoxB3 (N): Hybridomas secreting antibodies against CoxB3 (N) virus were obtained by fusing Sp2/0 myeloma cells with spleen cells from BALB/c mice immunized with the purified prototype CoxB3 (N) virions in the manner as described (11) . Hybridoma lines secreting antibodies specific to CoxB3 virus were screened by the micro-neutralization assay, further cloned by the limiting dilution, and checked again by the indirect immunofluorescence staining.
About one hundred of hybridoma clones were tested, and 16 of them produced antibody neutralizing the prototype CoxB3 (N). The clones which were negative in the neutralization assay were discarded. Five to 10 weeks old BALB/c mice were each primed by an ip injection of 0.5 ml of Pristane and inoculated 10-14 days later with 106 hybridoma cells. Tumors developed in 2 weeks. Ascitic fluids clarified by low-speed centrifugation were used as antibodies. 
Reactivities of McAbs with Prototype CoxB3 Virus
The CoxB3 Nancy strain was used for production of monoclonal antibodies .
The reactivities of the monoclonal antibodies (immune ascitic fluids) with ho- (Table I ). For example, antibody 10A2 had a neutralizing titer of 640 but its IF titer 25,600, while antibody 10A3 had a neutralizing titer of 10,240 but its IF titer only 100. The picornaviruses assemble in the cytoplasm .
In the infected cells, therefore, there are both unassembled and assembled proteins. 10A2 may have a higher avidity to unassembled proteins , while 10A3 to the neutralizing epitope of assembled virion. Alternatively , it is possible that 10A2 recognizes an epitope which plays a minor role in the neutralization reaction, while 10A3 recognizes the neutralization epitope and the sensitiving of neutralization is higher than that of IF. The cross-neutralizing activity of the monoclonal antibodies was checked with CoxB viruses type 1 to 6 . All the monoclonal antibodies were strictly type 3-specific (data not shown).
Reactivities of McAbs with Isolates of CoxB3
The 16 monoclonal antibodies were used for the antigenic analysis of three isolates obtained from Fujiang province , China. Each isolate was passaged three times in culture. All the strains were identified as coxsackievirus B3 by neutralization tests with the type-specific (anti-CoxB3) hyper-immune WHO reference serum which was provided by Chinese Academy of Medical Sciences , Institute of Medical Biology. F1, F2 and F3 from the myocarditis patients were neutralized by the same 12 monoclonal antibodies, but the epitopes recognized by monoclonal antibodies 5B5, 6C4, 9C3 and 10A2 were not shared by them all (Table II , (16) . Even during the passages of the virus without any selective pressure, the antigenic variation did occur at various epitopes recognized by the monoclonal antibodies.
The monoclonal antibody panel will be of use for epidemiological studies of
CoxB3.
